Knox Daily

1 day ago | knoxdaily.com | Daniel Torres

Delek US Holdings Inc’s filing revealed that its Chairman Yemin Ezra Uzi acquired Company’s shares for reported $75064.0 on Mar 14 ’25. In the deal valued at $15.40 per share,4,875 shares were bought. As a result of this transaction, Yemin Ezra Uzi now holds 833,145 shares worth roughly $10.92 million. Then, Marcogliese Richard J bought 1,540 shares, generating $22,458 in total proceeds. Upon buying the shares at $14.58, the Director now owns 44,933 shares.

1 day ago | knoxdaily.com | Daniel Torres

In a filing, Edwards Lifesciences Corp revealed its CVP,Strategy/Corp Development BOBO DONALD E JR unloaded Company’s shares for reported $0.66 million on Apr 14 ’25. In the deal valued at $69.81 per share,9,500 shares were sold. As a result of this transaction, BOBO DONALD E JR now holds 47,206 shares worth roughly $3.59 million. Then, Lippis Daniel J. sold 300 shares, generating $21,183 in total proceeds. Upon selling the shares at $70.61, the CVP, JAPAC now owns 22,863 shares.

1 day ago | knoxdaily.com | Daniel Torres

Gevo Inc’s recent filing unveils that its Chief Cust Mkt & Brnd Officer Shafer Andrew unloaded Company’s shares for reported $5572.0 on Apr 21 ’25. In the deal valued at $1.11 per share,5,000 shares were sold. As a result of this transaction, Shafer Andrew now holds 317,430 shares worth roughly $0.38 million. Then, Shafer Andrew sold 10,000 shares, generating $13,253 in total proceeds. Upon selling the shares at $1.33, the Chief Cust Mkt & Brnd Officer now owns 322,430 shares.

1 day ago | knoxdaily.com | Daniel Torres

In a filing, Microsoft Corporation revealed its EVP, Chief Marketing Officer Numoto Takeshi unloaded Company’s shares for reported $1.12 million on Dec 09 ’24. In the deal valued at $447.41 per share,2,500 shares were sold. As a result of this transaction, Numoto Takeshi now holds 49,352 shares worth roughly $19.34 million. Then, Numoto Takeshi sold 2,000 shares, generating $874,634 in total proceeds. Upon selling the shares at $437.32, the EVP, Chief Marketing Officer now owns 51,852 shares.

4 days ago | knoxdaily.com | Daniel Torres

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Travere Therapeutics Inc shares valued at $631 were sold by Cline Christopher R. on Apr 11 ’25. At $13.14 per share, Cline Christopher R. sold 48 shares. The insider’s holdings dropped to 89,990 shares worth approximately $1.59 million following the completion of this transaction. Also, Christopher Cline purchased 48 shares, netting a total of over 631 in proceeds. Before that, ROTE WILLIAM E.